Riskpilot← Back to searchSign inGet full accessTRY MEDICS ApS
APSActiveCVR 36089776Norgesvej 6BTour operator activities · NACE 7912Est. 20146 employeeshttps://trymedics.dk/
Revenue 2024
DKK 2,9M
+159% vs 2023
EBITDA margin
66.9%
+278% vs 2023
Equity ratio
38.9%
Financial strength
Net profit 2024
DKK 1,6M
+243% vs 2023
| Revenue | DKK 2,9M | +159% |
| EBITDA | DKK 2M | +278% |
| Net profit | DKK 1,6M | +243% |
| Total assets | DKK 6,7M | +26% |
| Equity | DKK 2,6M | +77% |
| Employees | 6 | — |
Legal name
TRY MEDICS ApS
CVR number
36089776
Legal form
Anpartsselskab
NACE code
7912 · Tour operator activities
Founded
11. september 2014
Share capital
DKK 50.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at anrrangere prækliniske praktikforhold for medicin-, sygepleje- og fysioterapi- og tandlægestuderende og hermed efter ledelsens skøn beslægtet virksomhed.
Address
Norgesvej 6B
Phone
+4550949148
Email
info@trymedics.com
Website
https://trymedics.dk/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 170 | 1.018 | 2.362 | 3.148 | 1.790 | 487 | 850 | 3.169 | 1.136 | 2.940 |
| Staff expenses | -50 | -169 | -362 | -661 | -772 | -726 | -604 | -610 | -615 | -974 |
| EBITDA | 120 | 849 | 2.000 | 2.487 | 1.018 | -239 | 247 | 2.559 | 521 | 1.966 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 120 | 849 | 2.000 | 2.487 | 1.018 | -239 | 247 | 2.559 | 521 | 1.966 |
| Net financials | 0 | -1 | 29 | -64 | 135 | -58 | 21 | 16 | 74 | 74 |
| Profit before tax | 120 | 849 | 2.029 | 2.423 | 1.153 | -296 | 268 | 2.575 | 595 | 2.041 |
| Tax | 28 | 187 | 449 | 534 | 257 | 9 | 59 | 562 | 131 | 450 |
| Net profit | 91 | 661 | 1.580 | 1.890 | 896 | -305 | 209 | 2.013 | 464 | 1.591 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.423 | 4.272 | 5.816 | 6.338 | 5.529 | 1.869 | 4.317 | 6.258 | 5.298 | 6.685 |
| Equity | 91 | 753 | 2.133 | 2.442 | 1.688 | 283 | 492 | 2.505 | 1.469 | 2.600 |
| Long-term debt | 200 | 200 | 0 | 0 | 0 | 564 | 583 | 451 | 0 | 0 |
| Short-term debt | 2.131 | 3.319 | 3.684 | 3.896 | 3.841 | 1.022 | 3.243 | 3.301 | 3.829 | 4.085 |
| Total debt | 2.331 | 3.519 | 3.684 | 3.896 | 3.841 | 1.586 | 3.826 | 3.753 | 3.829 | 4.085 |
EBITDA margin
66.9%
This company
15.8%
Market median
+323% vs market
20152024
Equity ratio
38.9%
This company
38.2%
Market median
+2% vs market
20152024
Return on equity
61.2%
This company
18.4%
Market median
+233% vs market
20152024
Net profit margin
54.1%
This company
8.1%
Market median
+568% vs market
20152024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20152024
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-09-11 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OA Management | Management | 2014 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
OLIGATER HOLDING ApS | Company | 66.7% | 66.7% | 2014 |
SONNY RASMUSSEN CONSULTING ApS | Company | 15.0% | 15.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OLIGATER HOLDING ApS
TRY MEDICS ApS Board members of TRY MEDICS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Oliver Andersen | Management | 0 companies |